Simris Alg AB (publ) Total Assets
Simris Alg AB (publ) total assets. Based on the latest financial reports, Simris Alg AB (publ) (SIMRIS-B) holds total assets worth Skr137.73 Million SEK (≈ $14.82 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Simris Alg AB (publ) worth for the company's overall valuation and market capitalisation.
Total Assets of Simris Alg AB (publ) (2012–2025)
Total assets of Simris Alg AB (publ) from 2012 to 2025. This chart illustrates how Simris Alg AB (publ)'s total assets have evolved over time, based on quarterly financial data. See SIMRIS-B stock price and chart for real-time trading data and today's change.
Simris Alg AB (publ) - Asset Composition Analysis
Simris Alg AB (publ) Total Assets Breakdown (December 2025)
Simris Alg AB (publ) total assets breakdown as of December 2025. Simris Alg AB (publ)'s total assets of Skr137.73 Million consist of 11.1% current assets and 88.9% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 1.0% |
| Accounts Receivable | Skr13.93 Million | 9.4% |
| Inventory | Skr1.08 Million | 0.7% |
| Property, Plant & Equipment | Skr11.36 Million | 7.7% |
| Intangible Assets | Skr120.55 Million | 81.3% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Simris Alg AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Simris Alg AB (publ) working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Simris Alg AB (publ)'s current assets represent 11.1% of total assets in 2025, a decrease from 89.3% in 2012.
- Cash Position: Cash and equivalents constituted 1.0% of total assets in 2025, down from 71.8% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 81.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is intangible assets at 81.3% of total assets.
Simris Alg AB (publ) Competitors by Total Assets
Key competitors of Simris Alg AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL
|
Belgium | €37.05 Million |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA
|
USA | $1.14 Billion |
|
Gempharmatech Co. Ltd. A
SHG:688046
|
China | CN¥2.80 Billion |
|
Vor Biopharma Inc
NASDAQ:VOR
|
USA | $481.05 Million |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
|
Sunmax Biotechnology Co Ltd
TWO:4728
|
Taiwan | NT$1.90 Billion |
|
Apnimed, Inc. Common Stock
NASDAQ:APMD
|
USA | $342.63 Million |
Simris Alg AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.81 | 0.10 | 1.01 |
| Quick Ratio | 0.71 | 0.08 | 0.43 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr-2.30 Million | Skr-20.65 Million | Skr75.00K |
Simris Alg AB (publ) - Advanced Valuation Insights
This section examines the relationship between Simris Alg AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 158.39 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -5.5% |
| Total Assets | Skr148.38 Million |
| Market Capitalization | $17.29 Million USD |
Valuation Analysis
Below Book Valuation: The market values Simris Alg AB (publ)'s assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Simris Alg AB (publ)'s assets decreased by 5.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Simris Alg AB (publ) (2012–2025)
The table below shows the annual total assets of Simris Alg AB (publ) from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr148.38 Million ≈ $15.97 Million |
-5.52% |
| 2024-12-31 | Skr157.06 Million ≈ $16.90 Million |
-10.02% |
| 2023-12-31 | Skr174.55 Million ≈ $18.78 Million |
-6.01% |
| 2022-12-31 | Skr185.71 Million ≈ $19.99 Million |
+535.98% |
| 2021-12-31 | Skr29.20 Million ≈ $3.14 Million |
-48.83% |
| 2020-12-31 | Skr57.06 Million ≈ $6.14 Million |
+9.31% |
| 2019-12-31 | Skr52.21 Million ≈ $5.62 Million |
+4.76% |
| 2018-12-31 | Skr49.84 Million ≈ $5.36 Million |
-8.37% |
| 2017-12-31 | Skr54.39 Million ≈ $5.85 Million |
-28.77% |
| 2016-12-31 | Skr76.35 Million ≈ $8.22 Million |
+37.27% |
| 2015-12-31 | Skr55.62 Million ≈ $5.99 Million |
+412.10% |
| 2014-12-31 | Skr10.86 Million ≈ $1.17 Million |
+71.52% |
| 2013-12-31 | Skr6.33 Million ≈ $681.52K |
-5.68% |
| 2012-12-31 | Skr6.71 Million ≈ $722.54K |
-- |
About Simris Alg AB (publ)
Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammen… Read more